Paul Edward Kelly, Director at RELMADA THERAPEUTICS, INC. (RLMD), sold 9,892 shares at $33.67 ($338K) on 2021-02-24, disclosed to the SEC on 2021-02-26.
Open-market sale of $338k RLMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.67 | 2,429 | $82K | 24.2% |
| 2 | $33.67 | 2,429 | $82K | 24.2% |
| 3 | $34.64 | 2,463 | $85K | 25.2% |
| 4 | $34.64 | 2,463 | $85K | 25.2% |
| 5 | $35.58 | 108 | $4K | 1.1% |
| Total | $34.17 avg | 9,892 |
| $338K |
| 100% |
| Filing → |
| RLMD | BUY | 2024-09-11 | $65K | — | Filing → |
| RLMD | SELL | 2022-04-05 | $300K | — | Filing → |
| RLMD | SELL | 2021-03-11 | $357K | — | Filing → |